This article has been corrected to note that Fugent is the owner of the FuGene technology, not Roche as previously reported.
NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced it will distribute Fugent's FuGene HD transfection reagent.
The product will be offered by Switchgear as a standalone product, as well as part of the company's LightSwitch Transfection Optimization kit.
"As part of SwitchGear's commitment to providing a complete reporter assay solution, we offer an start-to-finish system that will allow researchers to perform reporter assays quickly and easily without having to do any cloning or reagent optimization," Patrick Collin, director of R&D for the Menlo Park, Calif., company, said.
Terms of the distribution agreement were not disclosed.
SwitchGear was founded in 2005 by Stanford researchers and provides products for the study of regulatory elements in the human genome.